Join to access to all OVN content. Join for Free

Results for 'headcount'

Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms
OVN Avatar Angus Liu
Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms

headcount, reduction, revenue per employee

Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more than 22,000 employees last year.  Among the 17 largest pharma companies analyzed in a Fierce Pharma review of annual reports, only five logged a head count increase in 2025…

Mar 23rd • 10 mins read

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

hiring, talent demand, job market

As pipelines advance and execution accelerates, pharma and biotech hiring may shift again in 2026, reshaping talent demand.

Feb 4th • 7 mins read

Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs
Partner Avatar Michael Pietrack
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs

careers

In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.

Jun 25th • 4 mins read

Hiring Managers: What Should You Do During a Hiring Freeze?
Partner Avatar Michael Pietrack
Hiring Managers: What Should You Do During a Hiring Freeze?

careers

As we begin 2023, many companies are experiencing hiring freezes. Some hiring managers have a sense of how long the freeze will be, some don’t, but all know that it’s temporary. So, what can hiring managers do during the freeze to stay competitive in the war for talent? Hiring is a competition…

Jan 26th • 5 mins read

Related Topics

Meet Our Innovation Partners

Loading partners...